Upper limit of normothermic machine preservation of liver grafts from donation after circulatory death yet to be defined.

BACKGROUND

The normothermic machine perfusion pump (NMPP) could shape the future of transplantation. Providing optimization, NMPP attenuates ischemic insult while replenishing energy. An understanding of machine perfusion time (MPT) impact and potential clinical benefits is paramount and necessitates exploration.

AIM

To investigate the relationship between MPT and post-transplant graft function.

METHODS

Retrospective review of the first 50 donation after circulatory death (DCD) grafts preserved using NMPP in a tertiary institution was performed. Essential preservation time points, graft parameters, recipient information, and postoperative outcomes were prospectively recorded. Early allograft dysfunction (EAD), L-Graft score and 90-day outcomes were collected for all grafts. The first 20 recipients were allocated into the early group, considered the learning curve population for the center. The subsequent 30 were allocated into the late group. Recipients were also stratified into cohorts depending on MPT, , short (< 8 hours), medium (8-16 hours) and long (> 16 hours).

RESULTS

NMPP operational parameters were not predictive of EAD, L-GrAFT or 90-day outcomes. The early group had significantly less MPT and cold ischemia time than the late group (553 minutes 850 minutes, < 0.001) and (127.5 minutes 154 minutes, = 0.025), respectively. MPT had no impact in either group.

CONCLUSION

Increased MPT of DCD liver grafts had no adverse recipient results for the times utilized in this population, indicating its upper limits, likely beyond 24 hours, are not demonstrated within this study. Future studies are necessary to determine whether longer MPT is beneficial or detrimental to graft function and, if the latter, what is the maximum safe duration. Further studies of the effect of normothermic machine perfusion pump duration on long-term outcomes are also needed.